欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5897/001
药品名称Latanoprost JGL 50 microgram/ml eye drops, solution
活性成分
    • latanoprost 50.0 µg/ml
剂型Eye drops, solution
上市许可持有人Jadran - Galenski laboratorij d.d. Svilno 20 51000 Rijeka Croatia
参考成员国 - 产品名称Netherlands (NL)
Latanoprost JGL zonder conserveermiddel 50 microgram/ml oogdruppels, oplossing
互认成员国 - 产品名称
    • Slovenia (SI)
    • Croatia (HR)
许可日期2024/06/04
最近更新日期2024/06/13
药物ATC编码
    • S01EE01 latanoprost
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase